Sign Up to like & get
recommendations!
0
Published in 2018 at "Cytokine"
DOI: 10.1016/j.cyto.2018.05.017
Abstract: HighlightsSerum sCD163 levels correlated positively with the disease activity of s‐JIA, even in patients receiving tocilizumab.Serum sCD163 level is a potential diagnostic laboratory criterion for clinical remission in patients with s‐JIA.Serum sCD163 levels profoundly increased…
read more here.
Keywords:
scd163;
jia;
disease activity;
scd163 levels ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Disease Markers"
DOI: 10.1155/2018/8509583
Abstract: Objective To evaluate the performance of serum and urinary sCD163 concentrations as possible biomarker in systemic sclerosis (SSc). Methods Urine and serum samples were obtained from SSc patients and age- and sex-matched controls. Serum and…
read more here.
Keywords:
biomarker systemic;
ssc patients;
scd163;
urinary scd163 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Lupus"
DOI: 10.1177/09612033241276033
Abstract: Background The soluble CD163 (sCD163) was elevated in systemic lupus erythematosus (SLE) patients. Purpose To study whether serum sCD163 could be used to predict the occurrence and prognosis of lupus nephritis (LN). Research Design The…
read more here.
Keywords:
serum;
serum scd163;
lupus nephritis;
scd163 elevated ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Orphanet Journal of Rare Diseases"
DOI: 10.1186/s13023-020-01452-2
Abstract: Background Macrophages play a significant role in liver disease development and progression. The macrophage activation marker soluble (s)CD163 is associated with severity and prognosis in a number of different acute and chronic liver diseases but…
read more here.
Keywords:
liver disease;
disease phenotype;
scd163;
macrophage activation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15030897
Abstract: Simple Summary During the last decades, the CA 19-9 blood test has been the only widely used biomarker in patients with pancreatic ductal adenocarcinoma (PDAC). Given the poor prognosis and staggering mortality rates of this…
read more here.
Keywords:
ductal adenocarcinoma;
value;
patients pdac;
pancreatic ductal ... See more keywords